These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8364157)

  • 1. Proton magnetic resonance studies of bradykinin antagonists.
    Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
    Otter A; Bigler P; Stewart JM; Kotovych G
    Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aggregation properties of some bradykinin analogs.
    Liu X; Stewart JM; Cann JR; Gera L; Kotovych G
    J Biomol Struct Dyn; 1993 Aug; 11(1):169-79. PubMed ID: 8216942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
    Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
    J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the N-terminal beta-turn in bradykinin antagonists.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
    Sikorska Trzepałka E; Slusarz R; Lammek B
    J Biomol Struct Dyn; 2005 Oct; 23(2):125-34. PubMed ID: 16060686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution conformations of bradykinin antagonists modified with Calpha-Calpha cyclized nonaromatic residues.
    Sikorska E; Rodziewicz-Motowidło S
    J Pept Sci; 2008 Jul; 14(7):819-29. PubMed ID: 18219704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nmr and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lyso phosphatidylcholine micelles.
    Young JK; Hicks RP
    Biopolymers; 1994 May; 34(5):611-23. PubMed ID: 8003621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for cis' proline with alpha-aminoisobutyric acid substitution. N.m.r. studies of AIB substituted bradykinins.
    London RE; Schmidt PG; Vavrek RJ; Stewart JM
    Int J Pept Protein Res; 1982 Apr; 19(4):334-42. PubMed ID: 7118404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system.
    Mavunkel BJ; Lu Z; Goehring RR; Lu S; Chakravarty S; Perumattam J; Novotny EA; Connolly M; Valentine H; Kyle DJ
    J Med Chem; 1996 Aug; 39(16):3169-73. PubMed ID: 8759638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-turns induced in bradykinin by (S)-alpha-methylproline.
    Welsh JH; Zerbe O; von Philipsborn W; Robinson JA
    FEBS Lett; 1992 Feb; 297(3):216-20. PubMed ID: 1544400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
    Miskolzie M; Gera L; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.
    Cheronis JC; Whalley ET; Nguyen KT; Eubanks SR; Allen LG; Duggan MJ; Loy SD; Bonham KA; Blodgett JK
    J Med Chem; 1992 May; 35(9):1563-72. PubMed ID: 1578482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
    Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An NMR conformational analysis of cyclic bradykinin mimics. Evidence for a beta-turn.
    Miskolzie M; Yamamoto H; York EJ; Stewart JM; Kotovych G
    J Biomol Struct Dyn; 2000 Jun; 17(6):947-55. PubMed ID: 10949162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of bradykinin conformation in a dimethylsulfoxide solution by two-dimensional 1H-NMR spectroscopy].
    Saulitis IuB; Liepin'sh EE; Sekatsis IP; Mutulis FK; Chipens GI
    Bioorg Khim; 1986 Apr; 12(4):437-47. PubMed ID: 3718546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.